Form 4: Zepp Health Corp: Insider Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Zepp Health Corp's Chief Financial Officer, Cheng Deng, sold a portion of American Depositary Shares to cover tax obligations following the vesting of restricted share units.
Summary
- Cheng Deng, Chief Financial Officer of Zepp Health Corp, reported a transaction on June 26, 2026.
- This transaction involved the sale of 9,836 American Depositary Shares (ADSs) at a weighted average price of $4.61 per ADS.
- The sale was a 'sell-to-cover' transaction to satisfy tax withholding obligations related to the vesting of restricted share units (RSUs).
- Following the sale, Mr. Deng beneficially owns 114,539 ADSs.
- Additionally, 22,875 ADSs were acquired upon the vesting and settlement of RSUs, bringing the total beneficial ownership of ADSs to 124,375 before the sale.
- The RSUs were originally granted on April 1, 2026, and vested on June 26, 2026, with each RSU representing the right to one Class A ordinary share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves a sale of securities by an insider, it is explicitly for tax withholding purposes related to RSU vesting, a common and expected event.
Positives
- The company's Chief Financial Officer is actively managing their equity holdings and fulfilling tax obligations.
- The vesting of restricted share units indicates continued equity-based compensation and potential alignment of management interests with shareholders.
Negatives
- A portion of the insider's holdings were sold, which could be perceived negatively by the market, although it was for tax purposes.
- The sale price of $4.61 per ADS is noted, and the range of sale prices was between $4.31 and $4.8034.
Risks
- The sell-to-cover transaction, while standard for tax withholding, can sometimes be interpreted as a signal of an insider reducing their stake, potentially impacting investor sentiment.
- Fluctuations in the stock price within the reported range ($4.31 to $4.8034) could affect the final tax liability and the net proceeds for the reporting person.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports on past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. Such transactions, especially 'sell-to-cover' sales for tax withholding, are common and generally not indicative of a negative view on the company's prospects, provided they are proportionate to the tax liability.
Stakeholder Impact
- Shareholders: The sale is for tax withholding, so it's not a direct sale of shares based on market outlook. However, any insider selling can create short-term sentiment pressure.
- Management: Cheng Deng is managing his equity compensation and tax obligations.
- Creditors/Suppliers: No direct impact expected from this transaction.
Next Steps
- Continued monitoring of insider trading activity for any further transactions.
- Observation of the company's performance and strategic developments.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Date of earliest transaction and date of Restricted Share Unit grant. |
| 06/26/2026 | Date of transaction (sale of ADSs and vesting of RSUs). |
| 06/29/2026 | Date of signature on the filing. |
Keywords
Zepp Health Corp, ZEPP, Form 4, Insider Transaction, Cheng Deng, Chief Financial Officer, American Depositary Shares, Restricted Share Units, Sell-to-cover, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.